It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2012.
2012 | Nagpur, Maharashtra, India | ActiveSword Pharmaceuticals Private Limited, a active private limited company, was established on 13 March 2012 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232MH2012PTC227994. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Nisha Atul Urkude (Additional Director), Atul Bhagwanji Urkude (Director). Past directors included Bhagwan Dhonduji Urkude, Nisha Atul Urkude, Rajendra Vijay Patil. It holds ₹0.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 6, Om Sai Om, Karbi Road Shesh Nagar, Nagpur, Maharashtra, 440009.
U24232MH2012PTC227994
227994
13 March 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sword Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nisha Atul Urkude | Additional Director | 19 Jun 2025 | Current |
| Atul Bhagwanji Urkude | Director | 13 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 21 Apr 2017 | Past |
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sword Pharmaceuticals Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 1.13% decrease. The company also saw a substantial fall in profitability, with a 238.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Sword Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2020 | Others | ₹0.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sword Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sword Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sword Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sword Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Nisha Atul Urkude was appointed as a Additional Director was appointed as a Additional Director on 19 Jun 2025 & has been associated with this company since 5 months 16 days . was completed.
Progress on Sword Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 0.60 M with Charge ID 100322785 was registered on 27 Jan 2020. was documented.
The activity Atul Bhagwanji Urkude was appointed as a Director was appointed as a Director on 13 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
The activity Sword Pharmaceuticals Private Limited was registered on 13 Mar 2012 with Roc Mumbai & aged 13 years 8 months as per MCA records. was completed.
The CIN of Sword Pharmaceuticals Private Limited is U24232MH2012PTC227994.
Sword Pharmaceuticals Private Limited is headquartered at Plot No 6, Om Sai Om, Karbi Road Shesh Nagar, Nagpur, Maharashtra, 440009.
Sword Pharmaceuticals Private Limited was incorporated on 13 March 2012.
The current directors of Sword Pharmaceuticals Private Limited are
The primary industry of Sword Pharmaceuticals Private Limited is Pharma.
Sword Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sword Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sword Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX